Chem-structure (Chem Structure.jpg)
Maraviroc Tablet, Film Coated
Product Images NDC 72319-024
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Maraviroc (NDC 72319-024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by I3 Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Maraviroc-150mg (Maraviroc 150mg.jpg)
This text provides information about a medication called Maraviroc, which comes in the form of tablets containing 150 mg of the active ingredient. The recommended dosage and usage instructions can be found in the prescribing information. The medication should be stored at a temperature of 20°C to 25°C (68°F to 77°F) with allowable excursions between 15°C and 30°C (59°F and 86°F). It should be dispensed in tight containers. The medication is manufactured by i3 Pharmaceuticals, LLC, located in Warminster, PA 18974.*
Maraviroc-300mg (Maraviroc 300mg.jpg)
This text is a description of a medication called Maraviroc. Each tablet contains 300 mg of Maraviroc. The text advises to always dispense Maraviroc with a medication guide. The dosage and usage information can be found in the prescribing information. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). It warns not to use if the printed safety seal under the cap is broken or missing. The medication should be dispensed in tight containers. The manufacturing company is identified as i3 Pharmaceuticals, LLC based in Warminster, PA 18974.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
